NEUMORA THERAPEUTICS INC (NMRA) Stock Analyst Ratings
NASDAQ:NMRA - Nasdaq - US6409791000 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 74% to NMRA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.73. This target is 648% above the current price.
NMRA was analyzed by 14 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about NMRA.
In the previous month the buy percentage consensus was at a similar level.
NMRA was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-13 | Needham | Reiterate | Buy -> Buy |
| 2025-04-10 | Needham | Reiterate | Buy -> Buy |
| 2025-04-02 | B of A Securities | Downgrade | Buy -> Underperform |
| 2025-03-10 | Guggenheim | Downgrade | Buy -> Neutral |
| 2025-03-07 | Stifel | Downgrade | Buy -> Hold |
| 2025-03-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-04 | Needham | Reiterate | Buy -> Buy |
| 2025-03-04 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2025-03-04 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-02-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-06 | B of A Securities | Maintains | Buy -> Buy |
| 2025-01-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-02 | Needham | Reiterate | Buy -> Buy |
| 2024-12-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-22 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-11-13 | Needham | Reiterate | Buy -> Buy |
| 2024-11-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-05 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2024-10-18 | Needham | Reiterate | Buy -> Buy |
| 2024-10-01 | HC Wainwright & Co. | Initiate | Buy |
| 2024-09-12 | Needham | Reiterate | Buy -> Buy |
| 2024-09-04 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-08-07 | Needham | Reiterate | Buy -> Buy |
| 2024-07-22 | Needham | Initiate | Buy |
| 2024-07-08 | Mizuho | Initiate | Outperform |
| 2024-03-28 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-03-18 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-03-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-11-08 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-10-10 | Guggenheim | Initiate | Buy |